Bristol Myers Squibb Company is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.
Bristol Myers Squibb Co. is a pharmaceutical company that researches and develops medicines. It has made advancements in treatments of cancer, blood disorders, diabetes, and heart disease, among others. It also promotes better global access to medicines and health education.
(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)
Bristol Myers Squibb is responsible for positive Humankind Value largely because of its work in Healthcare R&D ($308.6 B), Pharmaceuticals ($132.7 B), and its Economic Value ($9.8 B). The last 150 years of medical innovation have contributed to modern life expectancies, which is why Healthcare is important to our measure of Humankind Value. The company produces economic value by offering to consumers goods and services that they value, paying employees for their labor in producing these goods and services, and providing value for shareholders. This company is among the ten best companies for Healthcare R&D and Pharmaceuticals out of the companies we measured. We estimate that its contributions in these fields added 9,156,364.5 additional life years globally. This firm can increase its Humankind Value by addressing Greenhouse Gases (-$2.6 B) and Air Pollution (-$540.8 M). Healthcare R&D, Pharmaceuticals, Economic Value, Greenhouse Gases, and Air Pollution are attached to this company as a result of its direct business activities.